AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
AAC.01025-07v1
52/6/2250    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Marchiaro, P.
Right arrow Articles by Vila, A. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchiaro, P.
Right arrow Articles by Vila, A. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2008, p. 2250-2252, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01025-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Biochemical Characterization of Metallo-β-Lactamase VIM-11 from a Pseudomonas aeruginosa Clinical Strain{triangledown} ,{dagger}

Patricia Marchiaro,1,{ddagger} Pablo E. Tomatis,2,{ddagger} María A. Mussi,1 Fernando Pasteran,3 Alejandro M. Viale,1 Adriana S. Limansky,1 and Alejandro J. Vila2*

Departamento de Microbiología,1 Departamento de Química Biológica, Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Buenos Aires, Argentina,2 Servicio Antimicrobianos, Departamento Bacteriología, Instituto Nacional de Enfermedades Infecciosas—ANLIS Dr. Carlos G. Malbrán, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina3

Received 3 August 2007/ Returned for modification 12 October 2007/ Accepted 15 March 2008

A detailed biochemical characterization of the Pseudomonas aeruginosa VIM-11 metallo-β-lactamase (MβL) is reported. The only substitution differentiating VIM-11 from VIM-2 (N165S) promoted a slightly improved catalytic efficiency of the former on 3 out of 12 substrates, notably the bulky cephalosporins. Thus, MβL-mediated resistance also may be modulated by remote mutations.


* Corresponding author. Mailing address: Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET), Departamento de Química Biológica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina. Phone: 54-341-4350661, ext. 108. Fax: 54-341-4390465. E-mail: vila{at}ibr.gov.ar

{triangledown} Published ahead of print on 24 March 2008.

{dagger} Supplemental material for this article may be found at http://aac.asm.org/.

{ddagger} These authors contributed equally to this work.


Antimicrobial Agents and Chemotherapy, June 2008, p. 2250-2252, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01025-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.